Intuitive Surgical, Inc. (NASDAQ:ISRG) Receives $595.95 Average Price Target from Analysts

Intuitive Surgical, Inc. (NASDAQ:ISRG) has been given a consensus recommendation of “Moderate Buy” by the twenty research firms that are currently covering the stock, MarketBeat Ratings reports. One research analyst has rated the stock with a sell recommendation, six have assigned a hold recommendation and thirteen have issued a buy recommendation on the company. The average twelve-month target price among brokerages that have covered the stock in the last year is $595.9524.

ISRG has been the topic of several analyst reports. Erste Group Bank reiterated a “hold” rating on shares of Intuitive Surgical in a research note on Wednesday, July 23rd. Deutsche Bank Aktiengesellschaft reissued a “sell” rating on shares of Intuitive Surgical in a report on Friday, August 22nd. Zacks Research lowered Intuitive Surgical from a “strong-buy” rating to a “hold” rating in a report on Wednesday, August 20th. BTIG Research increased their target price on Intuitive Surgical from $566.00 to $571.00 and gave the company a “buy” rating in a report on Wednesday, July 23rd. Finally, UBS Group increased their target price on Intuitive Surgical from $547.00 to $585.00 and gave the company a “neutral” rating in a report on Wednesday, July 23rd.

Insider Activity at Intuitive Surgical

In related news, Director Amy L. Ladd sold 336 shares of the stock in a transaction on Wednesday, September 3rd. The stock was sold at an average price of $470.11, for a total value of $157,956.96. Following the transaction, the director owned 1,074 shares of the company’s stock, valued at $504,898.14. This represents a 23.83% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. Also, EVP Myriam Curet sold 4,500 shares of the stock in a transaction on Friday, July 25th. The shares were sold at an average price of $492.48, for a total value of $2,216,160.00. Following the completion of the transaction, the executive vice president directly owned 353 shares in the company, valued at $173,845.44. This trade represents a 92.73% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 45,224 shares of company stock valued at $21,716,492 over the last quarter. 0.70% of the stock is owned by insiders.

Hedge Funds Weigh In On Intuitive Surgical

Several hedge funds have recently made changes to their positions in ISRG. AlphaCore Capital LLC increased its holdings in Intuitive Surgical by 4.2% in the 4th quarter. AlphaCore Capital LLC now owns 451 shares of the medical equipment provider’s stock valued at $235,000 after purchasing an additional 18 shares in the last quarter. Second Line Capital LLC increased its holdings in Intuitive Surgical by 3.4% in the 4th quarter. Second Line Capital LLC now owns 578 shares of the medical equipment provider’s stock valued at $302,000 after purchasing an additional 19 shares in the last quarter. Aaron Wealth Advisors LLC increased its holdings in Intuitive Surgical by 0.8% in the 2nd quarter. Aaron Wealth Advisors LLC now owns 2,528 shares of the medical equipment provider’s stock valued at $1,374,000 after purchasing an additional 19 shares in the last quarter. Crown Wealth Group LLC increased its holdings in Intuitive Surgical by 4.8% in the 1st quarter. Crown Wealth Group LLC now owns 440 shares of the medical equipment provider’s stock valued at $218,000 after purchasing an additional 20 shares in the last quarter. Finally, FSM Wealth Advisors LLC increased its holdings in Intuitive Surgical by 3.8% in the 1st quarter. FSM Wealth Advisors LLC now owns 546 shares of the medical equipment provider’s stock valued at $270,000 after purchasing an additional 20 shares in the last quarter. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Trading Up 1.3%

Shares of NASDAQ ISRG opened at $455.85 on Tuesday. The stock has a market cap of $163.41 billion, a P/E ratio of 63.58, a PEG ratio of 4.72 and a beta of 1.61. Intuitive Surgical has a 12-month low of $425.00 and a 12-month high of $616.00. The business’s fifty day simple moving average is $487.55 and its 200-day simple moving average is $509.57.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings data on Tuesday, July 22nd. The medical equipment provider reported $2.19 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.93 by $0.26. The business had revenue of $2.44 billion for the quarter, compared to analysts’ expectations of $2.35 billion. Intuitive Surgical had a return on equity of 14.56% and a net margin of 28.51%.The company’s revenue for the quarter was up 21.4% compared to the same quarter last year. During the same period last year, the firm earned $1.78 earnings per share. On average, equities analysts forecast that Intuitive Surgical will post 6.43 EPS for the current fiscal year.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.